Advertisement
Home Tags Cancer: Colon

Tag: Cancer: Colon

A scoring system can stratify risk for advanced colorectal neoplasia in asymptomatic adults

Index Stratifies Risk for Advanced Colorectal Neoplasia

Authors suggest scoring system may allow tailoring of screening methods in those at average risk
More than a third of colorectal cancers diagnosed in younger patients are caused by inherited gene mutations

35% of Colorectal Cancers in Patients Age ≤35 Are Genetic

Study authors recommend that people diagnosed before age 35 get tested
People living in 94 counties spread across the lower Mississippi Delta region

Pockets of U.S. Have Excessive Colorectal Cancer Mortality

Areas include parts of the Mississippi Delta, Appalachia, and eastern Virginia
Higher-quality colonoscopies are associated with a 50 to 60 percent lower risk for colorectal cancer and colorectal cancer fatalities over a patient's lifetime

Net Savings for Higher-Quality Colonoscopy

Those with higher polyp detection rates prevent more cancers, save more lives
The Affordable Care Act may have helped boost rates of colorectal cancer screening among lower income Americans

Rise in CRC Screening Rates After ACA Implementation

Increase in colonoscopy, other tests typically seen among poorer, less educated Americans
Incorporation of a genetic risk score can improve the accuracy of colorectal cancer risk determination

Model Including CRC Risk Alleles Ups Risk Discrimination

Model more accurately determines risk of colorectal cancer; defines recommended screening age
Population-based fecal immunochemical testing screening in adults aged 50 to 69 years can reduce colorectal cancer mortality

Population-Based FIT Screening Can Reduce CRC Mortality

Large cohort study shows significant reduction among screened 50- to 69-year-olds in Taiwan
For patients with refractory metastatic colorectal cancer

TAS-102 Ups Overall Survival in Refractory Metastatic CRC

Most frequently observed clinically significant adverse events include neutropenia, leukopenia
Use of a next-generation sequencing panel including genes associated with highly penetrant colorectal cancer and polyposis (CRCP) syndromes is cost-effective for CRCP diagnosis

Next-Generation Sequencing Panel Cost-Effective for CRC

Panel including genes linked to highly penetrant CRC and polyposis syndromes seems cost-effective
Screening rates for colorectal

CDC: CA Screening Rates Below Healthy People 2020 Targets

Includes tests for colorectal, breast, and cervical malignancies